| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $446,998,541 | 55 | 100 |
| McCarthy Cornelius P. III | director | 0 | $0 | 2 | $1.16M | $-1.16M |
| Carley Brian T | director | 0 | $0 | 1 | $3.04M | $-3.04M |
| Brady Kevin M. | CFO & Treasurer | 0 | $0 | 2 | $3.9M | $-3.9M |
| DAVENPORT FRED B JR | director | 0 | $0 | 1 | $4.41M | $-4.41M |
| Kraft Robert O. | director | 0 | $0 | 2 | $6.21M | $-6.21M |
| EWALD STEPHEN P | General Counsel & Corp. Secy. | 0 | $0 | 2 | $8.22M | $-8.22M |
| GEIGER JESSE J | President | 0 | $0 | 2 | $27.24M | $-27.24M |
| BURWIG SUSAN E | Exec. VP, Operations | 0 | $0 | 5 | $41.11M | $-41.11M |
| Troendle August J. | CEO | 0 | $0 | 38 | $351.7M | $-351.7M |
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing …
Over the last 12 months, insiders at Medpace Holdings, Inc. have bought $0 and sold $447M worth of Medpace Holdings, Inc. stock.
On average, over the past 5 years, insiders at Medpace Holdings, Inc. have bought $130.08M and sold $399.65M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2 shares for transaction amount of $652 was made by EWALD STEPHEN P (General Counsel & Corp. Secy.) on 2025‑02‑27.
| 2026-10-29 | Sale | EWALD STEPHEN P | General Counsel & Corp. Secy. | 1,245 0.0045% | $690.00 | $859,050 | -3.77% | |
| 2026-10-27 | Sale | BURWIG SUSAN E | Exec. VP, Operations | 3,940 0.0142% | $677.00 | $2.67M | -1.53% | |
| 2026-10-26 | Sale | BURWIG SUSAN E | Exec. VP, Operations | 16,060 0.0575% | $677.00 | $10.87M | -1.20% | |
| 2026-09-30 | Sale | Troendle August J. | President & CEO | 21,966 0.0789% | $625.47 | $13.74M | -0.43% | |
| 2026-09-29 | Sale | Troendle August J. | President & CEO | 26,701 0.0955% | $621.02 | $16.58M | +0.05% | |
| 2026-09-28 | Sale | Troendle August J. | President & CEO | 2,410 0.0086% | $620.07 | $1.49M | +1.03% | |
| 2026-09-25 | Sale | Troendle August J. | President & CEO | 154 0.0005% | $620.60 | $95,572 | +0.52% | |
| 2026-09-24 | Sale | Troendle August J. | President & CEO | 27,833 0.0998% | $621.33 | $17.29M | +0.12% | |
| 2026-09-23 | Sale | Troendle August J. | President & CEO | 16,083 0.0587% | $628.64 | $10.11M | +0.56% | |
| 2026-09-22 | Sale | Troendle August J. | President & CEO | 49,018 0.1801% | $628.11 | $30.79M | -1.53% | |
| 2026-09-21 | Sale | Troendle August J. | President & CEO | 21,883 0.0798% | $623.29 | $13.64M | -0.58% | |
| 2026-09-16 | Sale | Troendle August J. | President & CEO | 8,770 0.0317% | $621.29 | $5.45M | +0.67% | |
| 2026-09-15 | Sale | Troendle August J. | President & CEO | 15,971 0.0573% | $620.84 | $9.92M | +0.00% | |
| 2026-08-27 | Sale | Troendle August J. | President & CEO | 650 0.0023% | $620.27 | $403,176 | +0.91% | |
| 2026-08-26 | Sale | Troendle August J. | President & CEO | 4,000 0.0144% | $620.03 | $2.48M | -0.35% | |
| 2026-08-26 | Sale | Kraft Robert O. | director | 3,858 0.0138% | $617.81 | $2.38M | -0.35% | |
| 2026-08-25 | Sale | Troendle August J. | President & CEO | 673 0.0024% | $620.38 | $417,516 | +0.50% | |
| 2026-08-24 | Sale | Troendle August J. | President & CEO | 1,983 0.007% | $620.23 | $1.23M | -0.51% | |
| 2026-08-21 | Sale | Troendle August J. | President & CEO | 13,995 0.0497% | $624.45 | $8.74M | -0.58% | |
| 2026-08-20 | Sale | Troendle August J. | President & CEO | 27,174 0.0983% | $618.79 | $16.81M | +0.84% |
| Troendle August J. | President & CEO | 338225 1.2092% | $224.41M | 16 | 239 | +33.45% |
| BURWIG SUSAN E | Exec. VP, Operations | 54012 0.1931% | $35.84M | 2 | 18 | +3.69% |
| EWALD STEPHEN P | General Counsel & Corp. Secy. | 19098 0.0683% | $12.67M | 1 | 16 | +39.73% |
| DAVENPORT FRED B JR | director | 3798 0.0136% | $2.52M | 1 | 3 | +12.85% |
| Medpace Investors, LLC | 10 percent owner | 4733019 16.9207% | $3.14B | 14 | 178 | +37.6% |
| Increased Positions | 438 | +60.08% | 3M | +10.84% |
| Decreased Positions | 318 | -43.62% | 3M | -12.41% |
| New Positions | 172 | New | 364,156 | New |
| Sold Out Positions | 51 | Sold Out | 348,889 | Sold Out |
| Total Postitions | 849 | +16.46% | 24M | -1.57% |
| Blackrock, Inc. | $1.35M | 8.42% | 2.36M | -107,567 | -4.36% | 2025-09-30 |
| Vanguard Group Inc | $1.3M | 8.15% | 2.28M | -107,651 | -4.5% | 2025-09-30 |
| Aqr Capital Management Llc | $585,530.00 | 3.66% | 1.03M | +404,226 | +65.07% | 2025-09-30 |
| Wasatch Advisors Lp | $528,743.00 | 3.31% | 925,963 | -19,851 | -2.1% | 2025-09-30 |
| State Street Corp | $384,377.00 | 2.4% | 673,141 | -33,636 | -4.76% | 2025-09-30 |
| Mawer Investment Management Ltd. | $369,321.00 | 2.31% | 646,774 | -170,658 | -20.88% | 2025-09-30 |
| Geode Capital Management, Llc | $366,979.00 | 2.3% | 642,673 | +4,746 | +0.74% | 2025-09-30 |
| D. E. Shaw & Co., Inc. | $342,692.00 | 2.14% | 600,140 | +256,577 | +74.68% | 2025-09-30 |
| Baillie Gifford & Co | $333,930.00 | 2.09% | 584,796 | +62,503 | +11.97% | 2025-09-30 |
| Invesco Ltd. | $306,870.00 | 1.92% | 537,407 | +85,517 | +18.92% | 2025-09-30 |